MedPath

Reactions to Reduced Nicotine Cigarettes in Young Adult Low-Frequency Smokers

Not Applicable
Completed
Conditions
Nicotine Dependence
Interventions
Other: Very Low Nicotine Content Cigarettes
Other: Intermediate Nicotine Content Cigarettes
Other: Normal Nicotine Content Cigarettes
Registration Number
NCT02989038
Lead Sponsor
Duke University
Brief Summary

The purpose of this study is to evaluate reactions to, and choices to self-administer, cigarette smoke with varying nicotine content among low-frequency, non-dependent adolescent/young adult smokers between the ages of 15-25 years.

Detailed Description

Participants will undergo three sessions in which their reactions to fixed doses of smoke from investigational cigarettes with three different nicotine contents (15.8 mg/gram of tobacco, 2.5 mg/g, and .4 mg/g) will be assessed. Following the third fixed-dose session, participants will return to the lab to choose one of the cigarettes to self-administer.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
182
Inclusion Criteria
  • generally healthy
  • between the ages of 15-25
  • use nicotine or tobacco products between 1-15 days/month for at least 6 months
  • smokes at least 5 cigarettes/month
  • no unstable or significant medical or psychiatric conditions
  • breath alcohol value=0.000
  • able to provide contact information for two individuals who can corroborate smoking status
Read More
Exclusion Criteria
  • use of illegal drugs as measured by urine drug screen (excluding THC)
  • serious quit attempt in the past 3 months
  • plans to quit smoking in the next 2 months
  • current use of nicotine replacement therapy or other tobacco cessation products
  • inability to attend all required experimental sessions
  • blood pressure >160/100 mmHg
  • pregnant, trying to become pregnant, or breastfeeding
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
VLNC, INC, NNCIntermediate Nicotine Content CigarettesVery Low Nicotine Content, Intermediate Nicotine Content, Normal Nicotine Content
NNC, INC, VLNCIntermediate Nicotine Content CigarettesNormal Nicotine Content (NNC), Intermediate Nicotine Content (INC), Very Low Nicotine Content (VLNC)
NNC, INC, VLNCNormal Nicotine Content CigarettesNormal Nicotine Content (NNC), Intermediate Nicotine Content (INC), Very Low Nicotine Content (VLNC)
NNC, INC, VLNCVery Low Nicotine Content CigarettesNormal Nicotine Content (NNC), Intermediate Nicotine Content (INC), Very Low Nicotine Content (VLNC)
NNC, VLNC, INCVery Low Nicotine Content CigarettesNormal Nicotine Content, Very Low Nicotine Content, Intermediate Nicotine Content
NNC, VLNC, INCNormal Nicotine Content CigarettesNormal Nicotine Content, Very Low Nicotine Content, Intermediate Nicotine Content
INC, VLNC, NNCVery Low Nicotine Content CigarettesIntermediate Nicotine Content, Very Low Nicotine Content, Normal Nicotine Content
NNC, VLNC, INCIntermediate Nicotine Content CigarettesNormal Nicotine Content, Very Low Nicotine Content, Intermediate Nicotine Content
INC, NNC, VLNCVery Low Nicotine Content CigarettesIntermediate Nicotine Content, Normal Nicotine Content, Very Low Nicotine Content
VLNC, NNC, INCNormal Nicotine Content CigarettesVery Low Nicotine Content, Normal Nicotine Content, Intermediate Nicotine Content
VLNC, INC, NNCVery Low Nicotine Content CigarettesVery Low Nicotine Content, Intermediate Nicotine Content, Normal Nicotine Content
INC, VLNC, NNCIntermediate Nicotine Content CigarettesIntermediate Nicotine Content, Very Low Nicotine Content, Normal Nicotine Content
INC, NNC, VLNCIntermediate Nicotine Content CigarettesIntermediate Nicotine Content, Normal Nicotine Content, Very Low Nicotine Content
INC, NNC, VLNCNormal Nicotine Content CigarettesIntermediate Nicotine Content, Normal Nicotine Content, Very Low Nicotine Content
INC, VLNC, NNCNormal Nicotine Content CigarettesIntermediate Nicotine Content, Very Low Nicotine Content, Normal Nicotine Content
VLNC, NNC, INCVery Low Nicotine Content CigarettesVery Low Nicotine Content, Normal Nicotine Content, Intermediate Nicotine Content
VLNC, NNC, INCIntermediate Nicotine Content CigarettesVery Low Nicotine Content, Normal Nicotine Content, Intermediate Nicotine Content
VLNC, INC, NNCNormal Nicotine Content CigarettesVery Low Nicotine Content, Intermediate Nicotine Content, Normal Nicotine Content
Primary Outcome Measures
NameTimeMethod
Cigarette choice30 minutes after sampling all 3 study cigarettes

Participants will choose which of the three cigarettes they prefer to smoke by ranking each of the three cigarette conditions using a 1-3 scale where 1 is the cigarette that they most desire to smoke and 3 is the cigarette that they least desire to smoke.

Subjective reactions to fixed doses of tobacco smokeImmediately after puff administration of each study cigarette

Smoking Effects Questionnaire ratings following administration of puffs for NNC, INC, and VLNC cigarettes

Secondary Outcome Measures
NameTimeMethod
Mood and AffectImmediately after puff administration of each study cigarette

Minnesota Nicotine Withdrawal Scale (MNWS)

Smoking topography - Change in Carbon Monoxide (CO) values (in parts per million, ppm) following puff administrationImmediately after puff administration of each study cigarette

CO values (in ppm) will be obtained using a handheld CO monitor prior to puff administration and 5 minutes after completion of cigarette puff administration. The difference in values will provide a CO boost value

Smoking topography - interpuff intervalDuring self-administration of chosen cigarette at the last experimental session (approximately over 10 minutes)

Interpuff interval (in seconds) will be calculated using video recordings of self-administration of chosen cigarette

Smoking topography - number of puffsDuring self-administration of chosen cigarette at the last experimental session (approximately over 10 minutes)

number of puffs

Trial Locations

Locations (1)

Duke University Medical Center

🇺🇸

Durham, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath